In the following you will find a selection of publications about PentraSorb® CRP and about the pathological action of CRP sorted by topic.



Am J Case Rep. 2021 Dec 30. In Press: DOI: 10.12659/AJCR.935263
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry.
Schumann C, Heigl F, Rohrbach I, Sheriff A, Wagner L, Wagner F, Torzewski J.

Front. Immunol. 12:708101. doi: 10.3389/fimmu.2021.708101
Case Report: C- Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase.
Ringel J, Ramlow A, Bock C and Sheriff A.

Am J Case Rep. 2021 Jul 27: 22: e932964. doi: 10.12659/AJCR.932964
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis.
Torzewski J, Zimmermann O, Kayser S, Heigl F, Wagner F, Sheriff A, Schumann C.

Eur Heart J. 2021 Mar 29: ehab169, doi: 10.1093/eurheartj/ehab169
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?.
Pepys MB.

Eur Heart J. 2021 Jan 21: ehaa1103. doi: 10.1093/eurheartj/ehaa1103
C-reactive protein and clinical outcomes in patients with COVID-19.
Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS.

Cell Rep Med. 2020 Nov 17: 1;8. doi: 10.1016/j.xcrm.2020.100144
Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients.
Mueller AA, Tamura T, Crowley CP, DeGrado JR, Haider H, Jezmir JL, Keras G, Penn EH, Massaro AF, Kim EY.

MedPage Today 2020 Jul 27
Apheresis gets Tryout in COVID-19
Kate Kneisel

Am J Case Rep. 2020 Jul 14:21:e925020. doi: 10.12659/AJCR.925020
First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection.
Torzewski J, Heigl F, Zimmermann O, Wagner F, Schumann C, Hettich R, Bock C, Kayser S, Sheriff A.

Ther Apher Dial. 2020 Jun 05. doi: 10.1111/1744-9987.13532
Selective C-reactive protein apheresis for Covid-19 patients suffering from organ damage.
Kayser S, Kunze R, Sheriff A.